227 related articles for article (PubMed ID: 37981296)
21. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
22. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
[TBL] [Abstract][Full Text] [Related]
23. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
24. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
25. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
26. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
27. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957
[TBL] [Abstract][Full Text] [Related]
28. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
[TBL] [Abstract][Full Text] [Related]
31. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract][Full Text] [Related]
32. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
[TBL] [Abstract][Full Text] [Related]
34. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
35. Identification of a ferroptosis-associated gene signature and the related therapeutic targets in head and neck squamous carcinoma.
Huang Z; Li Y; Hong W; Chen X; Pan Y; Weng Y; Liu W; Wang L; Qiu S
Int Immunopharmacol; 2022 Jan; 102():108431. PubMed ID: 34906855
[TBL] [Abstract][Full Text] [Related]
36. Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Li J; Liu X; Nan S; Xu C
Free Radic Res; 2020 Apr; 54(4):254-270. PubMed ID: 32462956
[TBL] [Abstract][Full Text] [Related]
37. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
Zou J; Chu S; Bao Q; Zhang Y
Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma.
Lu C; Sun Q; Guo Y; Han X; Zhang M; Liu J; Wang Y; Mou Y; Li Y; Song X
Clin Transl Radiat Oncol; 2023 Nov; 43():100686. PubMed ID: 37854672
[TBL] [Abstract][Full Text] [Related]
39. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
40. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
